Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B.

@article{Brouwers2007ProteomicPO,
  title={Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B.},
  author={Frederieke M. Brouwers and Sven Glaesker and Amanda F Nave and Alexander O. Vortmeyer and Irina A. Lubensky and S Huang and Mones S. Abu-Asab and Graeme Eisenhofer and Robert J. Weil and Deric M. Park and W. Marston Linehan and Karel Pacak and Zhengping Zhuang},
  journal={Endocrine-related cancer},
  year={2007},
  volume={14 2},
  pages={463-71}
}
Pheochromocytomas are catecholamine-producing tumors that can occur in the context of von Hippel-Lindau syndrome (VHL) and multiple endocrine neoplasia type 2 (MEN2). Pheochromocytomas in these two syndromes differ in histopathological features, catecholamine metabolism, and clinical phenotype. To further investigate the nature of these differences, we compared the global protein expressions of 8 MEN2A-associated pheochromocytomas with 11 VHL-associated pheochromocytomas by two-dimensional gel… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Similar Papers

Loading similar papers…